Humana Inc (HUM) stock
HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3051% above fair value
$450.00+6.32 (+1.42%)
Close on Nov 13, 2026Market cap $54.04BP/E 43.6Yield 0.79%
Humana ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Humana's ebitda for the twelve months ending Sep 30, 2026 was $3.03B, down 18.5% year over year. For fiscal 2025 it was $3.40B, up 0.0% from the year before. Over ten years it grew 3.7% a year on average. The highest annual figure on record is $4.79B in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.40B | +0.0% |
| FY2024 | Dec 31, 2024 | $3.40B | -29.0% |
| FY2023 | Dec 31, 2023 | $4.79B | +6.3% |
| FY2022 | Dec 31, 2022 | $4.51B | +20.4% |
| FY2021 | Dec 31, 2021 | $3.74B | +5.6% |
| FY2018 | Dec 31, 2018 | $3.54B | -24.1% |
| FY2017 | Dec 31, 2017 | $4.67B | +119.4% |
| FY2016 | Dec 31, 2016 | $2.13B | -21.2% |
| FY2015 | Dec 31, 2015 | $2.70B | +0.4% |
| FY2014 | Dec 31, 2014 | $2.69B | +13.5% |
| FY2013 | Dec 31, 2013 | $2.37B | +0.7% |
| FY2012 | Dec 31, 2012 | $2.35B | -11.1% |
| FY2011 | Dec 31, 2011 | $2.65B | +25.0% |
| FY2010 | Dec 31, 2010 | $2.12B | +8.1% |
| FY2009 | Dec 31, 2009 | $1.96B | +51.4% |
| FY2008 | Dec 31, 2008 | $1.29B | -16.2% |
| FY2007 | Dec 31, 2007 | $1.54B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $233.00M | -59.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.52B | +19.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.92B | -12.7% |
| Q4 FY2025 | Dec 31, 2025 | -$644.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $573.00M | -38.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.28B | -5.7% |
| Q1 FY2025 | Mar 31, 2025 | $2.20B | +52.0% |
| Q4 FY2024 | Dec 31, 2024 | -$335.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $938.00M | -33.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.35B | -16.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.45B | -24.1% |
| Q4 FY2023 | Dec 31, 2023 | -$147.00M | -114.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.41B | +13.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.63B | +68.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.91B | +201.9% |
| Q3 FY2019 | Sep 30, 2019 | $1.01B | -5.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.24B | +27.4% |
| Q1 FY2019 | Mar 31, 2019 | $965.00M | +11.0% |
| Q4 FY2018 | Dec 31, 2018 | $631.00M | -6.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.07B | +11.8% |
| Q2 FY2018 | Jun 30, 2018 | $971.00M | -19.2% |
| Q1 FY2018 | Mar 31, 2018 | $869.00M | -52.7% |
| Q4 FY2017 | Dec 31, 2017 | $673.00M | – |
| Q3 FY2017 | Sep 30, 2017 | $960.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.20B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.84B | – |
| Q4 FY2016 | Dec 31, 2016 | -$339.00M | – |
See a number that looks wrong?